首页> 外文期刊>Journal of refractive surgery >Results of photorefractive keratectomy for hyperopia using the VISX star excimer laser system.
【24h】

Results of photorefractive keratectomy for hyperopia using the VISX star excimer laser system.

机译:使用VISX星准分子激光系统对远视进行屈光性角膜切削术的结果。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate safety, efficacy, and predictability of photorefractive keratectomy (PRK) for hyperopic astigmatism of +1.75 to 00 D manifest refractive sphere and up to -2.50 D manifest refractive astigmatism using the VISX Star excimer laser system, version 2.5 software. METHODS: Treatment was performed on 32 eyes of 21 patients. Eighteen of 21 patients were 45 years of age or older. Manifest and cycloplegic refraction together with Pelli-Robson contrast sensitivity assessment was performed prior to surgery and 1, 3, 6, 12, and 24 months after treatment. RESULTS: Twenty-seven of 32 surgical procedures were reviewed 1 year after treatment (84%). Corneal epithelial healing was complete between day 4 and 10. Twelve months after treatment, 25 of 27 eyes (93%) achieved 20/40 or better uncorrected visual acuity and 19 eyes (70%) achieved 20/20. No patient lost two or more lines of Snellen visual acuity assessed 6 months and later after treatment. The mean spherical equivalent refraction was reduced from +2.90 at baseline to +0.10 D at 1 year and +0.40 D at 2 years; 65% of eyes had a refraction within +/- 0.50 D. Four patients had further treatment by laser in situ keratomileusis for undercorrection in three eyes and overcorrection in one eye. Pelli-Robson contrast acuity was significantly reduced 12 months after treatment from a mean 1.72 before to 1.66 after PRK (P = .02, t-test). CONCLUSIONS: PRK for hyperopia using the VISX Star excimer laser system was effective in the treatment of hyperopic astigmatism. Although no patient lost two or more lines of high contrast best spectacle-corrected Snellen visual acuity 1 year after treatment, there was a significant decrease in Pelli-Robson contrast acuity.
机译:目的:使用版本2.5的VISX Star准分子激光系统,评估光屈光性角膜切除术(PRK)的远视散光为+1.75至00 D表现屈光球和至-2.50 D表现为屈光散光的安全性,有效性和可预测性。方法:对21例患者的32只眼进行了治疗。 21名患者中有18名年龄在45岁以上。术前,治疗后1、3、6、12和24个月进行了清单和睫状肌麻痹验光以及Pelli-Robson对比敏感性评估。结果:治疗后1年对32例外科手术中的27例进行了回顾(84%)。在治疗后的第4天至第10天,角膜上皮愈合完全。27眼中的25眼(93%)达到了20/40或更高的未矫正视力,19眼(70%)达到了20/20。在治疗后6个月及以后,没有患者失去两行或更多行Snellen视力评估。平均球当量折光率从基线的+2.90降低到1年的+0.10 D和2年的+0.40 D; 65%的眼睛屈光度在+/- 0.50 D之内。4例患者接受了激光原位角膜磨镶术进一步治疗,原因是三只眼矫正不足和一只眼矫正过度。治疗12个月后,Pelli-Robson对比敏锐度从PRK之前的平均1.72降低到PRK之后的1.66(P = .02,t检验)。结论:使用VISX Star准分子激光系统治疗远视的PRK可有效治疗远视散光。尽管没有患者在治疗后1年失去两行或更多行高对比度的最佳眼镜矫正Snellen视力,但Pelli-Robson的视力却明显下降。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号